Verma A K, Hsiao K M, Ahrens H, Suganuma M, Fujiki H, Matsufuji S, Hayashi H
Department of Human Oncology, Medical School, University of Wisconsin Comprehensive Cancer Center, Madison, USA.
Mol Cell Biochem. 1996 Feb 23;155(2):139-51. doi: 10.1007/BF00229311.
A correlation of the levels of epidermal protein kinase C (PKC) isozymes, steady state levels of ornithine decarboxylase (ODC) mRNA, and ODC antizyme with the induction of ornithine decarboxylase (ODC) activity by a second repeat 12-O-tetradecanoylphorbol-13-acetate (TPA) treatment to mouse skin was determined. A single application of TPA to female CD-1 mouse skin leads to a dramatic induction of ODC activity (approximately 3 nmol CO2/60 min/mg protein) which peaks at about 5 h after treatment. However, a superinduction of ODC activity (approximately 13 CO2/60 min/mg protein) is observed upon the second TPA application at 48 or 72 h after the first TPA treatment. Prior application of a tumor initiating dose of 7,12-dimethylbenz[a]anthracine to mouse skin did not influence the degree of induction of ODC by a repeat TPA treatment. Western Blot analyses using antibodies specific to PKC alpha, beta, gamma, delta and epsilon indicate detectable levels of PKC alpha, beta, delta and epsilon in mouse epidermal extracts. A time course of the effects of a single topical application of 20 nmol of TPA to the mouse skin indicate that none of PKC isozymes (alpha, beta, gamma, delta and epsilon) were completely downregulated at times (72 h) when ODC was overinduced by TPA. TPA-induced steady state levels of ODC mRNA did not correlate with the degree of superinduction of ODC activity by TPA. The second TPA treatment, 72 h after the first TPA treatment, which leads to superinduction of ODC activity did not decrease the levels of the ODC-antizyme. The results indicate that superinduction of mouse epidermal ODC activity is regulated in part post-transcriptionally and may not be the result of either a loss of PKC isoform(s) or a decrease in the levels of ODC antizyme.
测定了小鼠皮肤中表皮蛋白激酶C(PKC)同工酶水平、鸟氨酸脱羧酶(ODC)mRNA稳态水平和ODC抗酶与第二次重复使用12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)处理诱导鸟氨酸脱羧酶(ODC)活性之间的相关性。单次将TPA涂抹于雌性CD - 1小鼠皮肤会显著诱导ODC活性(约3 nmol CO₂/60分钟/毫克蛋白质),在处理后约5小时达到峰值。然而,在首次TPA处理后48或72小时进行第二次TPA涂抹时,会观察到ODC活性的超诱导(约13 nmol CO₂/60分钟/毫克蛋白质)。预先给小鼠皮肤施用致癌剂量的7,12 - 二甲基苯并[a]蒽并不影响重复TPA处理对ODC的诱导程度。使用针对PKCα、β、γ、δ和ε的特异性抗体进行的蛋白质印迹分析表明,在小鼠表皮提取物中可检测到PKCα、β、δ和ε的水平。单次局部施用20 nmol TPA至小鼠皮肤的时间效应过程表明,当TPA超诱导ODC时(72小时),PKC同工酶(α、β、γ、δ和ε)均未完全下调。TPA诱导的ODC mRNA稳态水平与TPA对ODC活性的超诱导程度无关。在首次TPA处理72小时后进行的第二次TPA处理导致ODC活性超诱导,但并未降低ODC抗酶的水平。结果表明,小鼠表皮ODC活性的超诱导部分受转录后调控,可能不是PKC同工型缺失或ODC抗酶水平降低的结果。